The invention relates to modified neomycin phosphotransferase genes and their use in a selection method for high-producing recombinant cells. The invention further relates to expression vectors which contain a modified neomycin phosphotransferase gene and a gene of interest functionally linked to a heterologous promoter and a method of preparing heterologous gene products using these expression vectors.

 
Web www.patentalert.com

< Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor

< Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases

> Methods and compositions for RNA interference using recombinant Dicer and Argonaut

> Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
~ 00614